Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flow

v3.22.4
Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities      
Net loss for the period $ (17,140) $ (22,938) $ (14,785)
Items not affecting cash:      
Stock based compensation 1,142 1,080 951
Net realizable value adjustments 6,861 7,000 7,802
Amortization of mineral properties 1,247 2,045 2,445
Depreciation of capital assets 1,768 1,789 1,818
Accretion expense 460 486 576
Amortization of deferred loan costs 43 46 71
Gain on loan forgiveness 0 (903) 0
Provision for reclamation (2) (5) 4
Mark to market loss (gain) (1,835) 5,998 680
Gain on sale of assets 67 0 (16)
Unrealized foreign exchange loss (gain) (25) 353 0
Accounts receivable (4) (4) 22
Inventory (8,841) (7,109) (8,190)
Prepaid expenses (136) (80) 71
Accounts payable and accrued liabilities (1,696) 544 108
Net Cash Provided by (Used in) Investing Activities (18,091) (11,698) (8,443)
Investing activities      
Proceeds from sale of capital assets 0 0 18
Purchase of capital assets (709) (1,190) (43)
Net Cash Provided by (Used in) Investing Activities (709) (1,190) (25)
Financing activities      
Issuance of common shares and warrants for cash 3,775 48,841 4,805
Share issue costs (94) (2,188) (431)
Proceeds from exercise of warrants and stock options 3,722 8,507 99
RSU redeemed for cash (205) (289) (39)
Proceeds from debt financing 0 0 893
Repayment of debt (1,305) 0 0
Net Cash Provided by (Used in) Financing Activities 5,893 54,871 5,327
Effects of foreign exchange rate changes on cash (108) 45 53
Increase (decrease) in cash, cash equivalents, and restricted cash (13,015) 42,028 (3,088)
Beginning cash, cash equivalents, and restricted cash 54,155 12,127 15,215
Ending cash, cash equivalents, and restricted cash $ 41,140 $ 54,155 $ 12,127